Myriad Genetics (MYGN) Deferred Taxes (2010 - 2025)

Myriad Genetics has disclosed Deferred Taxes across 16 years of filings, most recently posting $100000.0 for Q4 2025.

• In Q4 2025, Deferred Taxes fell 50.0% year-over-year to $100000.0; the TTM figure through Dec 2025 stood at -$1.1 million (up 60.71% YoY), while the FY2025 annual figure was $100000.0, up 103.57% from the prior year.
• Deferred Taxes retreated to $100000.0 in Q4 2025, from $200000.0 in the prior quarter.
• Over the last five years, Deferred Taxes for MYGN reached as high as $600000.0 in Q1 2024 and fell as low as -$16.3 million in Q3 2021.
• The 5-year median for Deferred Taxes is -$2.2 million (2024), against an average of -$4.1 million.
• Annual changes were most pronounced in 2022 — Deferred Taxes plunged 1666.67% — and 2024, when it surged 500.0%.
• A 5-year view of Deferred Taxes shows it stood at -$4.3 million in 2021, then tumbled by 104.65% to -$8.8 million in 2022, then surged by 73.86% to -$2.3 million in 2023, then surged by 108.7% to $200000.0 in 2024, then tumbled by 50.0% to $100000.0 in 2025.
• According to Business Quant data, Deferred Taxes over the past three periods registered $100000.0, $200000.0, and -$1.4 million for Q4 2025, Q4 2024, and Q3 2024 respectively.